Vasculitis & polymyalgia rheumatica

Meta-analysis revealed human leukocyte antigen (HLA) susceptibility markers in ANCA-associated vasculitis and its clinical subtypes

Rheumatology (Oxford)Published Systematic review and meta-analysis

Authors' conclusion

Multiple alleles of HLA-DRB1 and HLA-DPB1 were found to be associated with predisposition to AAV and its subtypes.

Study context

Population
Patients with ANCA-associated vasculitis (AAV) and five clinical subtypes; articles published March 2024 or previously
Comparison
HLA alleles in AAV and its subtypes
Outcome
Association of HLA alleles with AAV and its subtypes (meta-OR, Z test P)
Methodological detailsBonferroni correction, sensitivity analysis, GRADE, Newcastle-Ottawa Scale
  • Bonferroni correction
  • Sensitivity analysis
  • GRADE
  • Newcastle-Ottawa Scale

Pooled result

As reported in the abstract

Significant associations identified
30
Associations withstanding Bonferroni correction
17
rs9277554-C (HLA-DPB1), Meta-OR (P < 0.00001)
3.92 (3.27-4.69)
rs1049072-A (HLA-DQB1), Meta-OR (P < 0.00001)
1.39 (1.27-1.52)
rs9277341-C (HLA-DPA1), Meta-OR (P < 0.00001)
0.41 (0.03-0.57)
HLA-DRB1*09:01 and AAV, Meta-OR (P < 0.00001)
1.72 (1.46-2.03)
HLA-DRB1*09:01 and MPO+AAV, Meta-OR (P < 0.00001)
1.65 (1.41-1.93)
HLA-DRB1*09:01 and microscopic polyangiitis (MPA), Meta-OR (P < 0.00001)
1.75 (1.41-2.19)
HLA-DPB1*01:01 and AAV, Meta-OR (P ≤ 0.0005)
0.38 (0.24-0.62)
HLA-DRB1*11:01 and MPA, Meta-OR (P ≤ 0.0005)
2.11 (1.39-3.20)

Further pooled results

Sensitivity analysis

Additional significant (P ≤ 0.001) alleles HLA-DPB1*04:01 and HLA-DPB1*02:01 predisposing to AAV and to more than one subtype

Original publication

Meta-analysis revealed HLA susceptibility markers in ANCA-associated vasculitis and its clinical subtypes. Rheumatology (Oxford). Published 21 May 2025. doi:10.1093/rheumatology/keaf265

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.